Docket Room
HB 127·AL·house

Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.

In CommitteeFiled Jan 7, 2026
Sponsor: Brown (C)
Latest Action

Pending Committee Action in House of Origin

Jan 13, 2026

Summary

The bill stops the Alabama Board of Pharmacy, pharmacy employers, and pharmacy benefit managers from revoking, suspending, or otherwise penalizing pharmacists who suggest or fill off‑label prescriptions. It also lets anyone buy ivermectin and hydroxychloroquine over the counter, while keeping existing rules for controlled substances and untested off‑label uses. The change aims to give pharmacists the same legal protection physicians already have.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 127 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice